Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind ...

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive ...

The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June 2025.